Bio-Rad Launches Foresight™ Pro 45 cm Chromatography Columns for Biopharma Applications

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced the launch of Fores...

January 08, 2025 | Wednesday | News
GSK Secures FDA Breakthrough Therapy Designation for GSK5764227 in Relapsed Osteosarcoma

GSK plc (LSE/NYSE: GSK) announced  that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for GSK5764227 (GSK&rsq...

January 08, 2025 | Wednesday | News
Rise Therapeutics Completes Dose Escalation for R-2487 and R-3750, Advancing to Dose Expansion in Clinical Trials

Rise Therapeutics, a clinical-stage biotechnology company developing novel oral immunotherapeutic medicines,  announced that it has completed dose esc...

January 07, 2025 | Tuesday | News
Adcentrx Doses First Patient in Phase 1a/b Study of ADRX-0405 for Advanced Solid Tumors

 Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company advancing innovative protein conjugates for cancer and other life-thr...

January 07, 2025 | Tuesday | News
Norgine Files Marketing Authorization for Eflornithine in High-Risk Neuroblastoma with EMA

Norgine announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neurobl...

January 07, 2025 | Tuesday | News
TC BioPharm Shareholders Approve 25% Stock Dividend, Reinforcing Strong Financial Outlook

TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic ...

January 07, 2025 | Tuesday | News
Spyre Therapeutics Grants Stock Options to Non-Executive Employee as Part of Equity Inducement Award

Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company utilizing best-in-class antibody engineerin...

January 06, 2025 | Monday | News
LG NOVA Unveils Breakthrough Healthtech Solutions at CES 2025, Pioneering the Future of Remote Healthcare and Mental Wellbeing

LG NOVA, the North America Innovation Center for LG Electronics, returns to CES this year to showcase its commitment to a brighter future through building ...

January 06, 2025 | Monday | News
LPOXY Therapeutics to Acquire Key Assets from Xeno Biosciences to Advance C. difficile Infection Prevention Therapy

LPOXY Therapeutics, Inc. ("LPOXY"), a clinical-stage biopharmaceutical company focused on innovative therapies for infectious disease prevention, announced...

January 06, 2025 | Monday | News
TC BioPharm Advances Acquisition Talks to Expand Allogeneic T-Cell Therapy Platform

TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic ...

January 01, 2025 | Wednesday | News
Innocan Pharma Successfully Completes Non-Brokered Private Placement, Raising $635,444.60 to Advance CBD-Loaded Liposome Platform

Innocan Pharma Corporation (the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it has closed its previously announced no...

January 01, 2025 | Wednesday | News
Takeda Receives Japanese Regulatory Approval for HYQVIA® in Primary and Secondary Immunodeficiency Disorders

Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) announced that Takeda received regulatory approval for HYQVIA® [Immune Globulin Infusion 10%...

December 31, 2024 | Tuesday | News
Sangamo Therapeutics Regains Rights to Giroctocogene Fitelparvovec Following Pfizer's Decision to End Collaboration

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced it will regain development and commercialization rights to giroctocog...

December 31, 2024 | Tuesday | News
BMS Gains FDA Approval for Opdivo Qvantig, First Subcutaneous PD-1 Inhibitor with Three-Minute Administration

-Bristol Myers Squibb (NYSE: BMY)  announced that the U.S. Food and Drug Administration (FDA) granted approval for Opdivo Qvantig™&nbs...

December 30, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close